Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Chromobacterium violaceum Peptide chain release factor 1 (prfA) CSB-YP755882CKA
CSB-EP755882CKA
CSB-BP755882CKA
CSB-MP755882CKA
CSB-EP755882CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Protein CyaY (cyaY) CSB-YP755883CKA
CSB-EP755883CKA
CSB-BP755883CKA
CSB-MP755883CKA
CSB-EP755883CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable mannan synthase 2 (CSLA2), partial CSB-YP755884OFG1
CSB-EP755884OFG1
CSB-BP755884OFG1
CSB-MP755884OFG1
CSB-EP755884OFG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana ABC transporter G family member 43 (ABCG43), partial CSB-YP755885DOA
CSB-EP755885DOA
CSB-BP755885DOA
CSB-MP755885DOA
CSB-EP755885DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii DNA-directed RNA polymerase subunit beta' (rpoC2), partial CSB-YP755886DSJ
CSB-EP755886DSJ
CSB-BP755886DSJ
CSB-MP755886DSJ
CSB-EP755886DSJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Facilitated trehalose transporter Tret1 (Tret1), partial CSB-YP755887BZL
CSB-EP755887BZL
CSB-BP755887BZL
CSB-MP755887BZL
CSB-EP755887BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Gustatory and odorant receptor 22 (GPRgr22), partial CSB-YP755888BZL1
CSB-EP755888BZL1
CSB-BP755888BZL1
CSB-MP755888BZL1
CSB-EP755888BZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Eukaryotic translation initiation factor 3 subunit I (AGAP006607) CSB-YP755889BZL
CSB-EP755889BZL
CSB-BP755889BZL
CSB-MP755889BZL
CSB-EP755889BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Protein OPI10 homolog (AGAP002426) CSB-YP755890BZL
CSB-EP755890BZL
CSB-BP755890BZL
CSB-MP755890BZL
CSB-EP755890BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Heat shock protein 83 (Hsp83), partial CSB-YP755891BZL
CSB-EP755891BZL
CSB-BP755891BZL
CSB-MP755891BZL
CSB-EP755891BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae DNA-directed RNA polymerase II subunit RPB11 (Rpb11) CSB-YP755892BZL
CSB-EP755892BZL
CSB-BP755892BZL
CSB-MP755892BZL
CSB-EP755892BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Aquaporin AQPAn.G (AGAP008842), partial CSB-YP755893BZL1
CSB-EP755893BZL1
CSB-BP755893BZL1
CSB-MP755893BZL1
CSB-EP755893BZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Gustatory and odorant receptor 24 (GPRgr24), partial CSB-YP755894BZL1
CSB-EP755894BZL1
CSB-BP755894BZL1
CSB-MP755894BZL1
CSB-EP755894BZL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Probable cGMP 3',5'-cyclic phosphodiesterase subunit delta (PrBP) CSB-YP755895BZL
CSB-EP755895BZL
CSB-BP755895BZL
CSB-MP755895BZL
CSB-EP755895BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Mediator of RNA polymerase II transcription subunit 6 (MED6) CSB-YP755896BZL
CSB-EP755896BZL
CSB-BP755896BZL
CSB-MP755896BZL
CSB-EP755896BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Ribosome-releasing factor 2, mitochondrial (AGAP007894), partial CSB-YP755897BZL
CSB-EP755897BZL
CSB-BP755897BZL
CSB-MP755897BZL
CSB-EP755897BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Mediator of RNA polymerase II transcription subunit 24 (MED24), partial CSB-YP755899BZL
CSB-EP755899BZL
CSB-BP755899BZL
CSB-MP755899BZL
CSB-EP755899BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Neuropeptide F (npf) CSB-YP755900BZL
CSB-EP755900BZL
CSB-BP755900BZL
CSB-MP755900BZL
CSB-EP755900BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Lateral signaling target protein 2 homolog (AGAP003678), partial CSB-YP755901BZL
CSB-EP755901BZL
CSB-BP755901BZL
CSB-MP755901BZL
CSB-EP755901BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Sensory neuron membrane protein 1 (SCRB1), partial CSB-YP755902BZL
CSB-EP755902BZL
CSB-BP755902BZL
CSB-MP755902BZL
CSB-EP755902BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>